mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.3 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.5 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.9 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |